Miranda Machacek, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acetylglucosamine | 3 | 2020 | 189 | 1.310 |
Why?
|
Kidney Pelvis | 1 | 2024 | 195 | 0.860 |
Why?
|
Protein Processing, Post-Translational | 3 | 2020 | 1966 | 0.820 |
Why?
|
Hamartoma | 1 | 2023 | 236 | 0.750 |
Why?
|
Inclusion Bodies | 1 | 2020 | 279 | 0.650 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2020 | 648 | 0.590 |
Why?
|
Peptide Hydrolases | 1 | 2020 | 610 | 0.580 |
Why?
|
Oligonucleotides | 1 | 2020 | 563 | 0.580 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2020 | 261 | 0.570 |
Why?
|
Kidney Neoplasms | 2 | 2024 | 4300 | 0.560 |
Why?
|
Neoplasm Invasiveness | 1 | 2024 | 3629 | 0.530 |
Why?
|
Tuberous Sclerosis | 1 | 2023 | 1042 | 0.500 |
Why?
|
Interleukin-17 | 1 | 2019 | 925 | 0.420 |
Why?
|
Th17 Cells | 1 | 2019 | 791 | 0.410 |
Why?
|
Fatty Acids | 1 | 2019 | 1812 | 0.370 |
Why?
|
Neoplasm Staging | 1 | 2024 | 11262 | 0.330 |
Why?
|
Carcinoma, Renal Cell | 1 | 2023 | 3200 | 0.300 |
Why?
|
Enzyme Assays | 3 | 2015 | 103 | 0.290 |
Why?
|
beta-N-Acetylhexosaminidases | 2 | 2017 | 43 | 0.280 |
Why?
|
Macrophages | 1 | 2020 | 5800 | 0.250 |
Why?
|
N-Acetylglucosaminyltransferases | 2 | 2017 | 167 | 0.250 |
Why?
|
Leptospirosis | 1 | 2024 | 45 | 0.230 |
Why?
|
Jaundice | 1 | 2024 | 95 | 0.230 |
Why?
|
Ornithine-Oxo-Acid Transaminase | 1 | 2023 | 49 | 0.210 |
Why?
|
Sulfotransferases | 2 | 2015 | 150 | 0.210 |
Why?
|
Urothelium | 1 | 2024 | 276 | 0.200 |
Why?
|
Polyamines | 1 | 2023 | 133 | 0.200 |
Why?
|
Glycosyltransferases | 2 | 2015 | 114 | 0.200 |
Why?
|
Glycosylation | 2 | 2020 | 1101 | 0.170 |
Why?
|
Histocytochemistry | 1 | 2020 | 699 | 0.170 |
Why?
|
Acylation | 1 | 2019 | 98 | 0.160 |
Why?
|
Phosphoric Monoester Hydrolases | 2 | 2012 | 414 | 0.160 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2019 | 72 | 0.160 |
Why?
|
Pyrans | 1 | 2019 | 49 | 0.160 |
Why?
|
Immunoprecipitation | 1 | 2020 | 874 | 0.150 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2019 | 151 | 0.150 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2024 | 798 | 0.150 |
Why?
|
Fever | 1 | 2024 | 1620 | 0.140 |
Why?
|
Respiratory Insufficiency | 1 | 2024 | 1241 | 0.130 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2019 | 4413 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 1 | 2024 | 6546 | 0.110 |
Why?
|
Transcriptional Activation | 1 | 2019 | 1750 | 0.100 |
Why?
|
Glycosaminoglycans | 1 | 2015 | 611 | 0.100 |
Why?
|
Thiazoles | 1 | 2019 | 1542 | 0.100 |
Why?
|
Mitosis | 1 | 2016 | 1181 | 0.090 |
Why?
|
Golgi Apparatus | 1 | 2012 | 407 | 0.090 |
Why?
|
Disease Management | 1 | 2020 | 2537 | 0.080 |
Why?
|
Dimethylallyltranstransferase | 1 | 2009 | 8 | 0.080 |
Why?
|
Terpenes | 1 | 2009 | 102 | 0.080 |
Why?
|
Protein Binding | 2 | 2019 | 9344 | 0.080 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15471 | 0.070 |
Why?
|
Kidney | 1 | 2023 | 7057 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2024 | 65485 | 0.070 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 5801 | 0.070 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5505 | 0.070 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59738 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2017 | 2905 | 0.070 |
Why?
|
Humans | 13 | 2024 | 768887 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 5443 | 0.060 |
Why?
|
Leptospira | 1 | 2024 | 25 | 0.060 |
Why?
|
Cytokines | 1 | 2019 | 7453 | 0.060 |
Why?
|
Mitochondria | 1 | 2017 | 3683 | 0.060 |
Why?
|
Mice, Inbred C57BL | 2 | 2019 | 22381 | 0.050 |
Why?
|
Ornithine | 1 | 2023 | 79 | 0.050 |
Why?
|
Time Factors | 1 | 2024 | 40266 | 0.050 |
Why?
|
Doxycycline | 1 | 2024 | 349 | 0.050 |
Why?
|
Rosaniline Dyes | 2 | 2012 | 50 | 0.050 |
Why?
|
Animals | 5 | 2023 | 169408 | 0.050 |
Why?
|
Mice | 4 | 2023 | 82074 | 0.040 |
Why?
|
Metabolomics | 1 | 2009 | 1675 | 0.040 |
Why?
|
Adult | 3 | 2024 | 223818 | 0.040 |
Why?
|
Arginine | 1 | 2023 | 932 | 0.040 |
Why?
|
Phosphates | 2 | 2015 | 765 | 0.040 |
Why?
|
Aged | 2 | 2024 | 171790 | 0.040 |
Why?
|
Kinetics | 3 | 2012 | 6334 | 0.040 |
Why?
|
Middle Aged | 2 | 2024 | 223740 | 0.040 |
Why?
|
Male | 4 | 2024 | 365249 | 0.030 |
Why?
|
Obesity | 1 | 2019 | 13087 | 0.030 |
Why?
|
Radioactivity | 1 | 2015 | 59 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2015 | 6512 | 0.030 |
Why?
|
Female | 2 | 2024 | 397464 | 0.030 |
Why?
|
Biopsy | 1 | 2024 | 6805 | 0.030 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2023 | 1756 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1608 | 0.020 |
Why?
|
Reference Standards | 1 | 2015 | 1014 | 0.020 |
Why?
|
Glucosyltransferases | 1 | 2010 | 94 | 0.020 |
Why?
|
Sialyltransferases | 1 | 2010 | 83 | 0.020 |
Why?
|
Colorimetry | 1 | 2010 | 151 | 0.020 |
Why?
|
HeLa Cells | 1 | 2016 | 3076 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3951 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6131 | 0.020 |
Why?
|
Pliability | 1 | 2009 | 58 | 0.020 |
Why?
|
Prenylation | 1 | 2009 | 37 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2024 | 13020 | 0.020 |
Why?
|
Naphthoquinones | 1 | 2009 | 59 | 0.020 |
Why?
|
Diphosphates | 1 | 2009 | 89 | 0.020 |
Why?
|
Streptomyces | 1 | 2009 | 91 | 0.020 |
Why?
|
Liver | 1 | 2024 | 7579 | 0.020 |
Why?
|
Diterpenes | 1 | 2009 | 170 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2012 | 1751 | 0.020 |
Why?
|
Bacterial Proteins | 2 | 2010 | 3839 | 0.020 |
Why?
|
Lung | 1 | 2024 | 10097 | 0.020 |
Why?
|
Bacterial Toxins | 1 | 2010 | 921 | 0.020 |
Why?
|
Phosphorylation | 1 | 2016 | 8317 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2017 | 14485 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2024 | 20776 | 0.010 |
Why?
|
Binding Sites | 1 | 2009 | 6023 | 0.010 |
Why?
|
Proteins | 1 | 2010 | 6011 | 0.010 |
Why?
|
Signal Transduction | 1 | 2016 | 23652 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2009 | 20244 | 0.010 |
Why?
|